跳至主要内容
临床试验/NCT00092716
NCT00092716已完成3 期

A Multicenter, Double-Blind, Randomized, Parallel Group, 28-Week Study to Evaluate the Efficacy and Safety of Ezetimibe and Simvastatin Co-administration Versus Atorvastatin in Patients With Hypercholesteremia

Organon and Co0 个研究点目标入组 655 人开始时间: 2002年5月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
655
主要终点
To evaluate the effect on the reduction in low density lipoprotein cholesterol (LDL-C) after the initial 6-week treatment period.

研究概览

简要总结

The purpose of this study is to determine whether an investigational medication will be more effective than an approved medication in reducing cholesterol levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elevated cholesterol levels

排除标准

  • Liver disease
  • Unstable medical conditions

结局指标

主要结局

To evaluate the effect on the reduction in low density lipoprotein cholesterol (LDL-C) after the initial 6-week treatment period.

次要结局

  • Assess safety/tolerability and evaluate effect on HDL-C & on reduction of LDL-C
  • Evaluate % of pts who attain their NCEP-ATP III goal for LDL-C @ each dose level

研究者

申办方类型
Industry
责任方
Sponsor

相似试验